糖尿病牙周炎中的线粒体功能障碍:机制和治疗潜力
Leilei Meng1,2, Wenjie Wen1
1Anhui Province Engineering Research Center for Dental Materials and Application, School of Stomatology, Wannan Medical College, Wuhu, 241002, People's Republic of China.
Journal of inflammation research
|January 15, 2025
概括
线粒体功能障碍显著导致糖尿病牙周炎,这是一个常见的糖尿病并发症. 准线粒体为糖尿病患者改善口腔健康提供了有希望的治疗策略.
科学领域:
- 口腔生物学 口腔生物学
- 内分泌学 在内分泌学.
- 线粒体生物学 线粒体生物学
背景情况:
- 糖尿病牙周炎涉及牙周组织的逐渐破坏,是糖尿病的常见并发症.
- 新出现的证据强调线粒体功能障碍是糖尿病牙周炎病原和进展的关键因素.
研究的目的:
- 系统地审查线粒体功能障碍在糖尿病牙周炎中的作用和机制.
- 探索这种疾病的潜在治疗点和未来研究方向.
主要方法:
- 对糖尿病,线粒体功能障碍和牙周炎的现有文献进行系统审查.
- 分析分子机制,包括氧化应激,亡和炎症.
- 确定针对线粒体功能的潜在治疗策略.
主要成果:
- 糖尿病牙周炎中的线粒体功能障碍表现为形态变化,代谢障碍,氧化应激增加和亡.
- 功能失调的线粒体会加剧炎症,损害组织修复,并在牙周炎中失调自.
- 治疗策略包括抗氧化剂,针对线粒体的药物和自调节剂.
结论:
- 线粒体功能障碍是糖尿病牙周炎病原体的核心.
- 准线粒体通路为新型治疗干预提供了一个有希望的途径.
- 对于分子机制,诊断和个性化治疗,需要进一步的研究.
更多相关视频
相关概念视频
Pathophysiology of Diabetes
859
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
859
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Diabetes: Symptoms, Diagnosis, and Complications
500
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
500
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K


